B. C. Dow

3.4k total citations
44 papers, 2.1k citations indexed

About

B. C. Dow is a scholar working on Hepatology, Epidemiology and Management of Technology and Innovation. According to data from OpenAlex, B. C. Dow has authored 44 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 30 papers in Epidemiology and 6 papers in Management of Technology and Innovation. Recurrent topics in B. C. Dow's work include Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (28 papers) and Liver Disease Diagnosis and Treatment (10 papers). B. C. Dow is often cited by papers focused on Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (28 papers) and Liver Disease Diagnosis and Treatment (10 papers). B. C. Dow collaborates with scholars based in United Kingdom, United States and Slovakia. B. C. Dow's co-authors include E. A. C. Follett, F. McOmish, Peter Simmonds, Shiu‐Wan Chan, P.L. Yap, P.L. Yap, J F Peutherer, Edward C. Holmes, R. Naukkarinen and Tom Krusius and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Hepatology and Journal of General Virology.

In The Last Decade

B. C. Dow

43 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. C. Dow United Kingdom 19 1.8k 1.6k 243 231 138 44 2.1k
Dale Netski United States 24 1.2k 0.7× 1.2k 0.8× 467 1.9× 199 0.9× 137 1.0× 42 2.0k
Yi‐Hua Zhou China 26 1.0k 0.6× 1.1k 0.7× 488 2.0× 140 0.6× 227 1.6× 99 1.8k
Patricia E. Hewitt United Kingdom 24 910 0.5× 583 0.4× 501 2.1× 32 0.1× 676 4.9× 75 2.5k
Bianca Bruzzone Italy 23 471 0.3× 850 0.5× 948 3.9× 58 0.3× 202 1.5× 120 1.8k
Katy Davison United Kingdom 19 251 0.1× 574 0.4× 271 1.1× 36 0.2× 20 0.1× 54 1.3k
Alan D. Kitchen United Kingdom 20 815 0.5× 674 0.4× 397 1.6× 16 0.1× 55 0.4× 45 1.7k
Roberto Focaccia Brazil 17 447 0.3× 736 0.5× 323 1.3× 12 0.1× 41 0.3× 52 1.3k
Evaldo Stanislau Affonso de Araújo Brazil 16 574 0.3× 536 0.3× 356 1.5× 17 0.1× 57 0.4× 35 1.0k
Sheena Sutherland United Kingdom 20 100 0.1× 965 0.6× 343 1.4× 62 0.3× 70 0.5× 37 1.5k
Richard Smith United States 8 395 0.2× 660 0.4× 822 3.4× 55 0.2× 124 0.9× 10 1.5k

Countries citing papers authored by B. C. Dow

Since Specialization
Citations

This map shows the geographic impact of B. C. Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. C. Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. C. Dow more than expected).

Fields of papers citing papers by B. C. Dow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. C. Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. C. Dow. The network helps show where B. C. Dow may publish in the future.

Co-authorship network of co-authors of B. C. Dow

This figure shows the co-authorship network connecting the top 25 collaborators of B. C. Dow. A scholar is included among the top collaborators of B. C. Dow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. C. Dow. B. C. Dow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dow, B. C., et al.. (2012). Hepatitis B escape mutants in Scottish blood donors. Medical Microbiology and Immunology. 202(3). 207–214. 15 indexed citations
2.
Davison, Katy, B. C. Dow, J. A. J. Barbara, Patricia E. Hewitt, & Roger Eglin. (2009). The introduction of anti‐HTLV testing of blood donations and the risk of transfusion‐transmitted HTLV, UK: 2002–2006. Transfusion Medicine. 19(1). 24–34. 18 indexed citations
3.
Dow, B. C., et al.. (2009). Syphilis nucleic acid testing: usefulness in syphilis confirmation?. Transfusion. 50(3). 737–739. 4 indexed citations
4.
5.
Galea, George & B. C. Dow. (2006). Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland. Vox Sanguinis. 91(1). 28–33. 10 indexed citations
6.
Davidson, Fordyce A., C. D. L. Lycett, Erwin Sablon, Juraj Petrík, & B. C. Dow. (2005). Hepatitis B virus genotypes and precore mutations in Scottish blood donors. Vox Sanguinis. 88(2). 87–92. 26 indexed citations
7.
Jarvis, Lisa, B. C. Dow, Alexandra A. Cleland, et al.. (2005). Detection of HCV and HIV‐1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sanguinis. 89(3). 128–134. 22 indexed citations
8.
Dow, B. C., Ian Buchanan, Kristi J. Ferguson, et al.. (2004). Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening. Vox Sanguinis. 86(1). 15–20. 8 indexed citations
9.
Soldan, Kate, J. A. J. Barbara, & B. C. Dow. (2002). Transfusion‐transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sanguinis. 83(4). 305–308. 22 indexed citations
10.
Dow, B. C., Kristi J. Ferguson, Ian Buchanan, et al.. (2001). HTLV antibody screening using mini‐pools. Transfusion Medicine. 11(6). 419–422. 9 indexed citations
11.
Dow, B. C., Ian Buchanan, E. A. C. Follett, et al.. (1996). Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. Journal of Medical Virology. 49(2). 132–136. 43 indexed citations
12.
Prescott, L. E., B. C. Dow, Fordyce A. Davidson, et al.. (1996). Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. Journal of Medical Virology. 48(2). 184–190. 42 indexed citations
13.
Bird, George, E. Spence, Kenneth J. Hillan, et al.. (1995). Genotypic variation, clinical and histological characteristics of chronic hepatitis C detected at blood donor screening. Journal of Viral Hepatitis. 2(5). 261–265. 4 indexed citations
14.
Dow, B. C., et al.. (1993). Confirmation of hepatitis C virus antibody in blood donors. Journal of Medical Virology. 41(3). 215–220. 35 indexed citations
15.
16.
Simmonds, Peter, Ken A. Rose, Susan M. Graham, et al.. (1993). Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. Journal of Clinical Microbiology. 31(6). 1493–1503. 216 indexed citations
17.
Garson, Jeremy A., J. P. Clewley, Peter Simmonds, et al.. (1992). Hepatitis C Viraemia in United Kingdom Blood Donors: A Multicentre Study. Vox Sanguinis. 62(4). 218–223. 37 indexed citations
18.
Chan, Shiu‐Wan, F. McOmish, Edward C. Holmes, et al.. (1992). Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. Journal of General Virology. 73(5). 1131–1141. 372 indexed citations
19.
Cossar, J H, Daniel Reid, R.J. Fallon, et al.. (1990). A cumulative review of studies on travellers, their experience of illness and the implications of these findings. Journal of Infection. 21(1). 27–42. 127 indexed citations
20.
Challis, P., et al.. (1988). ‘Sequential’ ELISA for Anti‐HIV Should not Replace the Standard Competitive Method. Vox Sanguinis. 55(4). 244–245. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale Netski Breakdown of academic impact, for papers by Yi‐Hua Zhou Breakdown of academic impact, for papers by Patricia E. Hewitt Breakdown of academic impact, for papers by Bianca Bruzzone Breakdown of academic impact, for papers by Katy Davison Breakdown of academic impact, for papers by Alan D. Kitchen Breakdown of academic impact, for papers by Roberto Focaccia Breakdown of academic impact, for papers by Evaldo Stanislau Affonso de Araújo Breakdown of academic impact, for papers by Sheena Sutherland Breakdown of academic impact, for papers by Richard Smith
Rankless by CCL
2026